Scott Kellen
Overview
Scott Kellen received an average of $592K in total compensation, including $285K in salary, at DiaMedica Therapeutics from 2018 to 2023.
2023DiaMedica TherapeuticsChief Financial Officer and Secretary
2022DiaMedica TherapeuticsChief Financial Officer and Secretary
2021DiaMedica TherapeuticsChief Financial Officer and Secretary
2020DiaMedica TherapeuticsChief Financial Officer and Secretary
2019DiaMedica TherapeuticsChief Financial Officer and Secretary
2018DiaMedica TherapeuticsChief Financial Officer and Secretary
Source: SEC filings on April 4, 2024, April 4, 2023, April 5, 2022, April 20, 2020, and April 8, 2019.
Related executives
We found five more executives who work or worked at DiaMedica Therapeutics.
Rick Pauls
DiaMedica Therapeutics
Chief Executive Officer
Kirsten Gruis
DiaMedica Therapeutics
Chief Medical Officer
Julie Daves
DiaMedica Therapeutics
SVP, Clinical Development Operations
Harry Alcorn
DiaMedica Therapeutics
Senior Vice President of Clinical Operations
Todd Verdoorn
DiaMedica Therapeutics
Chief Scientific Officer
News
DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
April 4, 2024
DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
April 4, 2023
DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
April 5, 2022
DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
April 20, 2020
DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
April 8, 2019